Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Experimental hepatitis B vaccine includes a novel adjuvant; efficacy in nonresponders

Oct. 12, 1999

Cerus awarded NIH grant for allogeneic bone marrow transplant research

Oct. 12, 1999

Animal model shows Toleragen reduces production of antiphospholipid antibodies

Oct. 12, 1999

Immunostimulatory oligonucleotide enhances immune response to HBV vaccine in animals

Oct. 8, 1999

Japanese researchers isolate and characterize two related immunosuppressants

Oct. 8, 1999

Shionogi's new immunosuppressant/antiallergic compounds

Oct. 4, 1999

BioTransplant achieves milestone in xenotransplantation collaboration with Novartis

Oct. 1, 1999

Antex Biologics and SB restructure agreement

Sep. 29, 1999

ER-49890 prolongs graft survival in murine transplantation models

Sep. 28, 1999

NCI to lead phase II trial of Repligen's CTLA4-Ig

Sep. 28, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...